Clarity for the deal.
Confidence for the build.
Independent operating advice for medical device companies and investors — 30+ years of medical-device leadership across product development, manufacturing scale-up and general management, helping investors and executives make better technical and operational decisions.
For Investors
Technical and operational due diligence before capital commits — clarity for the deal.
DUE DILIGENCE → 2For CEOs
Scale-up, manufacturing transfer and organizational execution — confidence for the build.
OPERATING SUPPORT → 3For Boards
Independent, ongoing operating and strategic advice from someone who has run the function.
ADVISORY →We do not compete with your CDMO. We don't sell manufacturing capacity, and we don't manufacture your product.
We provide independent technical and operational advice so you can select, manage and hold your manufacturing partners accountable — Truestead Advisors is not a CDMO, and never becomes one.
One relationship, built to compound.
A single transaction can open into years of engagement — diligence into a 100-day plan, into scale-up support, into standing leadership or a board seat.
Field notes from the operating side of the table
Diligence vs. the 100-day plan
Diligence asks whether the operation can support the thesis. The 100-day plan asks what happens first, and who owns it.
DUE DILIGENCE · OCT 6, 2026Five things I look for in manufacturing diligence
Real capacity, live validation status, CAPA trends, single points of failure, and key-person risk.
DUE DILIGENCE · OCT 1, 2026The 14-week quote that became nine months
A vendor quoted 14 weeks for equipment central to the ramp. After close, it was closer to nine months.
Before you invest more, make sure it can actually be built.
If you're weighing a medical-device transaction, or running one, an independent operator's read on the technical and manufacturing story is a phone call away.